DE69928002T2 - Verfahren zur herstellung von mycophenolatestern - Google Patents
Verfahren zur herstellung von mycophenolatestern Download PDFInfo
- Publication number
- DE69928002T2 DE69928002T2 DE69928002T DE69928002T DE69928002T2 DE 69928002 T2 DE69928002 T2 DE 69928002T2 DE 69928002 T DE69928002 T DE 69928002T DE 69928002 T DE69928002 T DE 69928002T DE 69928002 T2 DE69928002 T2 DE 69928002T2
- Authority
- DE
- Germany
- Prior art keywords
- enzyme
- morpholinoethanol
- organic solvent
- hours
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical class OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229960000951 mycophenolic acid Drugs 0.000 claims abstract description 25
- KKFDCBRMNNSAAW-UHFFFAOYSA-N 2-(morpholin-4-yl)ethanol Chemical compound OCCN1CCOCC1 KKFDCBRMNNSAAW-UHFFFAOYSA-N 0.000 claims abstract description 24
- RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 claims abstract description 15
- 229960004866 mycophenolate mofetil Drugs 0.000 claims abstract description 15
- 239000003054 catalyst Substances 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 claims description 7
- 108090001060 Lipase Proteins 0.000 claims description 7
- 239000004367 Lipase Substances 0.000 claims description 7
- 102000004882 Lipase Human genes 0.000 claims description 7
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 claims description 7
- 235000019421 lipase Nutrition 0.000 claims description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 7
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 108090000371 Esterases Proteins 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical group [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 108010093096 Immobilized Enzymes Proteins 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 238000010992 reflux Methods 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 3
- WNWVKZTYMQWFHE-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound [CH2]CN1CCOCC1 WNWVKZTYMQWFHE-UHFFFAOYSA-N 0.000 abstract 1
- 229950007856 mofetil Drugs 0.000 abstract 1
- 229940014456 mycophenolate Drugs 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 13
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000008351 acetate buffer Substances 0.000 description 6
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000235395 Mucor Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 108010005400 cutinase Proteins 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- -1 morpholinoethyl ester Chemical class 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- AQZSPJRLCJSOED-UHFFFAOYSA-M trimethyl(octyl)azanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)C AQZSPJRLCJSOED-UHFFFAOYSA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000222175 Diutina rugosa Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- MOTXQRYFCVJNEK-UHFFFAOYSA-L disodium;2,2-di(octan-3-yl)-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCC(CC)C(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)C(CC)CCCCC MOTXQRYFCVJNEK-UHFFFAOYSA-L 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| INMA275498 | 1998-12-09 | ||
| IN2754MA1998 IN188985B (enExample) | 1998-12-09 | 1998-12-09 | |
| PCT/IN1999/000070 WO2000034503A2 (en) | 1998-12-09 | 1999-12-09 | Methods of producing esters of mycophenolate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69928002D1 DE69928002D1 (de) | 2005-12-01 |
| DE69928002T2 true DE69928002T2 (de) | 2006-07-27 |
Family
ID=11096895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69928002T Expired - Lifetime DE69928002T2 (de) | 1998-12-09 | 1999-12-09 | Verfahren zur herstellung von mycophenolatestern |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6709846B1 (enExample) |
| EP (1) | EP1137795B1 (enExample) |
| AT (1) | ATE307892T1 (enExample) |
| AU (1) | AU3073200A (enExample) |
| CA (1) | CA2354554C (enExample) |
| DE (1) | DE69928002T2 (enExample) |
| DK (1) | DK1137795T3 (enExample) |
| ES (1) | ES2252995T3 (enExample) |
| IN (1) | IN188985B (enExample) |
| WO (1) | WO2000034503A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003042393A1 (en) * | 2001-11-16 | 2003-05-22 | Biocon Limited | Enzymatic preparation of mycophenolate mofetil |
| TWI221414B (en) * | 2003-02-21 | 2004-10-01 | Chunghwa Chemical Synthesis & | Method of making mycophenolate mofetil using transesterification |
| WO2005023791A2 (en) * | 2003-09-11 | 2005-03-17 | Sandoz Ag | Process for the production of mycophenolate mofetil |
| TW200613294A (en) * | 2004-04-26 | 2006-05-01 | Teva Gyogyszergyar Reszvenytarsasag | Process for preparation of mycophenolic acid and ester derivatives thereof |
| WO2005105769A2 (en) * | 2004-04-27 | 2005-11-10 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg - | Mycophenolate mofetil impurity |
| US7439373B2 (en) * | 2004-07-20 | 2008-10-21 | TEVA Gyógyszergyár Zártkörúen Múködö Részvénytársaság | Crystalline mycophenolate sodium |
| ITMI20041703A1 (it) * | 2004-09-03 | 2004-12-03 | Poli Ind Chimica Spa | Metodo di preparazione del mofetil micofenolato per transesterificazione enzimatica |
| US20080281111A1 (en) * | 2005-04-26 | 2008-11-13 | Sandor Molnar | Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid |
| CN1328272C (zh) * | 2005-08-22 | 2007-07-25 | 鲁南制药集团股份有限公司 | 一种工业化生产霉酚酸莫啡酯的方法 |
| CN100402516C (zh) * | 2005-10-18 | 2008-07-16 | 深圳市东阳光实业发展有限公司 | 一种霉酚酸莫啡酯的制备方法 |
| US20080188653A1 (en) | 2007-02-04 | 2008-08-07 | Formosa Laboratories, Inc. | Process for Preparation of Mycophenolate Mofetil |
| CN100484930C (zh) * | 2007-03-16 | 2009-05-06 | 重庆大新药业股份有限公司 | 一种吗替麦考酚酯的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753935A (en) | 1987-01-30 | 1988-06-28 | Syntex (U.S.A.) Inc. | Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions |
| US5247083A (en) * | 1992-07-10 | 1993-09-21 | Syntex (U.S.A.) Inc. | Direct esterification of mycophenolic acid |
| DK0724581T3 (da) * | 1993-09-15 | 1999-08-02 | Syntex Inc | Krystallinsk vandfri mycophenolatmofetil og intravenøs formulering deraf |
-
1998
- 1998-12-09 IN IN2754MA1998 patent/IN188985B/en unknown
-
1999
- 1999-12-09 AT AT99964770T patent/ATE307892T1/de not_active IP Right Cessation
- 1999-12-09 AU AU30732/00A patent/AU3073200A/en not_active Abandoned
- 1999-12-09 DK DK99964770T patent/DK1137795T3/da active
- 1999-12-09 ES ES99964770T patent/ES2252995T3/es not_active Expired - Lifetime
- 1999-12-09 EP EP99964770A patent/EP1137795B1/en not_active Expired - Lifetime
- 1999-12-09 DE DE69928002T patent/DE69928002T2/de not_active Expired - Lifetime
- 1999-12-09 WO PCT/IN1999/000070 patent/WO2000034503A2/en not_active Ceased
- 1999-12-09 US US09/857,579 patent/US6709846B1/en not_active Expired - Fee Related
- 1999-12-09 CA CA2354554A patent/CA2354554C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69928002D1 (de) | 2005-12-01 |
| US6709846B1 (en) | 2004-03-23 |
| DK1137795T3 (da) | 2006-03-20 |
| WO2000034503A2 (en) | 2000-06-15 |
| ES2252995T3 (es) | 2006-05-16 |
| CA2354554A1 (en) | 2000-06-15 |
| EP1137795A2 (en) | 2001-10-04 |
| CA2354554C (en) | 2010-05-25 |
| IN188985B (enExample) | 2002-11-30 |
| AU3073200A (en) | 2000-06-26 |
| ATE307892T1 (de) | 2005-11-15 |
| EP1137795B1 (en) | 2005-10-26 |
| WO2000034503A3 (en) | 2000-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928002T2 (de) | Verfahren zur herstellung von mycophenolatestern | |
| EP0475255A2 (de) | Verfahren zur Herstellung optisch reiner (S)-alpha-[(tert-Butylsulfonyl)methyl]hydrozimtsäure | |
| DE3872924T2 (de) | Verfahren zur herstellung von optisch aktiven verbindungen. | |
| DE3424440A1 (de) | Verfahren zur herstellung optisch aktiver carbonsaeuren und deren ester in form der optischen antipoden | |
| DE3876039T2 (de) | Verfahren zur herstellung von optisch aktiven verbindungen mit pyridin-kernen. | |
| EP0802261B1 (de) | Enzymatische Acylierung eines Retinolderivates | |
| DE69021711T2 (de) | Verfahren zur Herstellung von optisch aktiven Hydroxylactonen. | |
| EP0337920B1 (de) | Verfahren zur hochregioselektiven Veresterung und Esterspaltung an ungesättigten Zuckerverbindungen mit Hilfe von Lipasen und Esterasen und mit diesem Verfahren herstellbare Produkte | |
| DE69732772T2 (de) | Enzymatisches verfahren zur stereoselektiven herstellung von therapeutischen amiden | |
| DE69205851T2 (de) | Verfahren zur Herstellung von (-)-(2R,3S)-2,3-Epoxy-3-(4-Methoxyphenyl)propionat-methylester. | |
| DE69813053T2 (de) | Verfahren zur Herstellung von optisch aktiven Azetidin-2-Carbonsäurederivaten | |
| EP0507278A2 (de) | Immobilisierter Biokatalysator, dessen Herstellung und Verwendung zur Estersynthese in einem Säulenreaktor | |
| DE69221024T2 (de) | Verfahren zur Herstellung von Ascorbinsäure-Estern oder Erythorbinsäure-Estern | |
| DE69721812T2 (de) | Verfahren zur herstellung optisch aktiver 3-quinuclidinol derivate | |
| DE602005004557T2 (de) | Verfahren zur herstellung von mycophenolat-mofetil mittels enzymatischer umesterung | |
| AT398579B (de) | Enzymatisches verfahren zur trennung racemischer gemische von delta-valerolactonen | |
| EP0511526A1 (de) | Verfahren zur enzymatischen Hydrolyse eines Carbonsäurederivates | |
| DE69226942T2 (de) | Verfahren zur herstellung von optisch aktivem norborneol | |
| DE69618268T2 (de) | Verfahren zur enzymatischen Herstellung eines Synthese-Zwischenprodukt von Befloxatone | |
| DE3724721A1 (de) | Verfahren zur enzymatischen racematspaltung von 1-acyloxy-2-cyclopenten-4-on(2,2- dimethylpropandiol)-ketal | |
| DE60010013T2 (de) | Verfahren zur Herstellung von optisch aktivem 1,2,4-Butantriol und optisch aktivem 3-Hydroxy-gamma-butyrolacton mittels Mikroorganismen | |
| EP0759926B1 (de) | Verfahren zur herstellung von arabinonukleosiden | |
| DE69123402T2 (de) | Verfahren zur Herstellung optisch aktiver Alpha-Hydroxyalkenderivate | |
| EP0254243A2 (de) | Chirale Synthesebausteine aus prochiralem Glycerin | |
| EP0388778B1 (de) | Herstellung von Dioxolanderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |